No black box warning on record for Padcev Ejfv

As of the latest FDA labeling reviewed, Padcev Ejfv (ENFORTUMAB VEDOTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Padcev Ejfv medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hyperglycemia: Diabetic ketoacidosis may occur in patients with and without preexisting diabetes mellitus, which may be fatal. Closely monitor blood glucose levels in patients with, or at risk for, diabetes mellitus or hyperglycemia. Withhold PADCEV if blood glucose is >250 mg/dL. ( 2.2 , 5.2 ) • Pneumonitis/Interstitial Lung Disease (ILD): Severe, life-threatening or

No black box warning on record for Padcev Ejfv

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hyperglycemia: Diabetic ketoacidosis may occur in patients with and without preexisting diabetes mellitus, which may be fatal. Closely monitor blood glucose levels in patients with, or at risk for, diabetes mellitus or hyperglycemia. Withhold PADCEV if blood glucose is >250 mg/dL. ( 2.2 , 5.2 ) • Pneumonitis/Interstitial Lung Disease (ILD): Severe, life-threatening or

Padcev Ejfv Black Box Warning

No black box warning on record for Padcev Ejfv

Other warnings & precautions

Padcev Ejfv Black Box Warning

No black box warning on record for Padcev Ejfv

Other warnings & precautions